Loading clinical trials...
Loading clinical trials...
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an ep...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neurocrine Biosciences
NCT07140913 · Mania, Bipolar Disorder
NCT07540338 · Bipolar I Disorder
NCT00344188 · Leishmaniasis, Skin Diseases, Parasitic, and more
NCT07494305 · Bipolar I Disorder
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
Neurocrine Clinical Site
Garden Grove, California
Neurocrine Clinical Site
Hollywood, California
Neurocrine Clinical Site
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions